6 days ago
KNSA
AnalystsGeoff MeachamGeoff Meacham's Stock Forecasts
AnalystsGeoff Meacham
Analyst Ranking
Top 9%
#466 out of 5342 analysts
Average Return
+9.33%
Win Rate
55%112 out of 203
Risk vs Reward
Poor
Good
Geoff Meacham's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Amylyx Pharmaceuticals IncAMLX | +182.36% | $5.33 | $15.05 | 2025-06-17 - 2026-06-16 | Strong Buy |
Bridgebio Pharma IncBBIO | +161.09% | $27.19 | $70.99 | 2024-11-25 - 2025-11-24 | Strong Buy |
Coherent CorpCOHR | +150.48% | $26.29 | $65.85 | 2020-03-23 - 2021-03-23 | Strong Buy |
Checkmate Pharmaceuticals IncCMPI | +144.76% | $4.29 | $10.50 | 2021-10-06 - 2022-05-27 | Strong Buy |
Kymera Therapeutics IncKYMR | +131.69% | $33.45 | $77.50 | 2025-03-13 - 2026-03-12 | Strong Buy |
Geoff Meacham Analyst Color
Get additional color on Geoff Meacham's coverage of popular stocks
19 days ago
MANE
20 days ago
LLY
25 days ago
ABBV
2 months ago
TYRA
2 months ago
PTCT
3 months ago
RPRX
4 months ago
MGTX
4 months ago
APGE
5 months ago
PTGX
5 months ago
VRTX
5 months ago
SRRK
5 months ago
AMLX
6 months ago
MRK
6 months ago
GILD
6 months ago
MRK
6 months ago
RPRX
8 months ago
PTGX
10 months ago
PTGX
10 months ago
NAMS
10 months ago
KYMR
10 months ago
KNSA
10 months ago
AMLX
10 months ago
GILD
10 months ago
AMLX
Geoff Meacham's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Amylyx Pharmaceuticals IncAMLX | 7 | Strong Buy | $26.00 | +28.90% | Maintains | 14 hours ago |
Regeneron Pharmaceuticals IncREGN | 13 | Hold | $740.00 | -2.53% | Maintains | 15 hours ago |
Moderna IncMRNA | 9 | Hold | $60.00 | +8.81% | Maintains | 15 hours ago |
Bristol Myers Squibb CoBMY | 9 | Hold | $70.00 | +6.92% | Maintains | 15 hours ago |
Biogen IncBIIB | 20 | Hold | $215.00 | +6.53% | Maintains | 15 hours ago |
Kiniksa Pharmaceuticals International PLCKNSA | 6 | Strong Buy | $100.00 | +36.22% | Maintains | 6 days ago |
Veradermics IncMANE | 3 | Strong Buy | $160.00 | +57.03% | Maintains | 19 days ago |
Eli Lilly & CoLLY | 11 | Strong Buy | $1,600.00 | +42.68% | Maintains | 20 days ago |
Abbvie IncABBV | 24 | Hold | $260.00 | +6.08% | Maintains | 20 days ago |
Apogee Therapeutics IncAPGE | 4 | Hold | $135.00 | +0.66% | Downgrades | a month ago |
Tyra Biosciences IncTYRA | 3 | Strong Buy | $42.00 | +31.09% | Maintains | 2 months ago |
Ptc Therapeutics IncPTCT | 11 | Strong Buy | $108.00 | +58.56% | Assumes | 2 months ago |
Regenxbio IncRGNX | 2 | Strong Buy | $14.00 | +40.56% | Maintains | 3 months ago |
Royalty Pharma PLCRPRX | 5 | Strong Buy | $66.00 | +15.45% | Maintains | 3 months ago |
Merck & Co IncMRK | 13 | Hold | $125.00 | -2.17% | Reinstates | 3 months ago |
Pfizer IncPFE | 8 | Hold | $27.00 | +7.87% | Maintains | 3 months ago |
Gilead Sciences IncGILD | 10 | Strong Buy | $165.00 | +25.81% | Maintains | 4 months ago |
Meiragtx Holdings PLCMGTX | 2 | Strong Buy | $16.00 | +34.68% | Maintains | 4 months ago |
Protagonist Therapeutics IncPTGX | 5 | Strong Buy | $125.00 | -5.50% | Maintains | 5 months ago |
Biontech SeBNTX | 3 | Strong Buy | $130.00 | +40.92% | Maintains | 5 months ago |
Biomarin Pharmaceutical IncBMRN | 4 | Strong Buy | $85.00 | +41.68% | Maintains | 5 months ago |
Vertex Pharmaceuticals IncVRTX | 6 | Strong Buy | $585.00 | +24.28% | Maintains | 5 months ago |
Scholar Rock Holding CorpSRRK | 2 | Strong Buy | $58.00 | +26.50% | Maintains | 5 months ago |
Kymera Therapeutics IncKYMR | 8 | Strong Buy | $120.00 | +19.63% | Maintains | 5 months ago |
Arcellx IncACLX | 2 | Hold | $115.00 | -0.06% | Downgrades | 5 months ago |
Amgen IncAMGN | 12 | Hold | $345.00 | -8.94% | Maintains | 6 months ago |
Vor Biopharma IncVOR | 1 | Strong Buy | $50.00 | +133.54% | Initiates Coverage On | 7 months ago |
Janux Therapeutics IncJANX | 3 | Strong Buy | $49.00 | +219.84% | Maintains | 8 months ago |
Acumen Pharmaceuticals IncABOS | 6 | Strong Buy | $8.00 | +266.97% | Maintains | 9 months ago |
Avidity Biosciences IncRNAM | 8 | Hold | $72.00 | +388.14% | Downgrades | 9 months ago |
Newamsterdam Pharma Co NvNAMS | 2 | Strong Buy | $50.00 | +81.88% | Maintains | 10 months ago |
Crispr Therapeutics AgCRSP | 4 | Strong Buy | $93.00 | +87.61% | Maintains | 10 months ago |
Vir Biotechnology IncVIR | 3 | Strong Buy | $14.00 | +57.30% | Upgrades | a year ago |
Bridgebio Pharma IncBBIO | 6 | Strong Buy | $54.00 | N/A | Maintains | a year ago |
Novavax IncNVAX | 1 | Strong Sell | $6.00 | N/A | Initiates Coverage On | a year ago |
Neumora Therapeutics IncNMRA | 3 | Sell | $1.00 | N/A | Downgrades | a year ago |
89bio IncETNB | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | a year ago |
Bioxcel Therapeutics IncBTAI | 5 | Sell | $4.00 | N/A | Downgrades | 2 years ago |
Lyell Immunopharma IncLYEL | 3 | Sell | $20.00 | N/A | Downgrades | 2 years ago |
Turnstone Biologics CorpTSBX | 2 | Strong Buy | $10.00 | N/A | Maintains | 2 years ago |
Johnson & JohnsonJNJ | 2 | Hold | $170.00 | N/A | Maintains | 2 years ago |
LianbioLIANY | 1 | Sell | $3.00 | N/A | Downgrades | 3 years ago |
Igm Biosciences IncIGMS | 2 | Hold | $8.00 | N/A | Downgrades | 3 years ago |
Curevac NvCVAC | 4 | Sell | $8.00 | N/A | Maintains | 3 years ago |
Rani Therapeutics Holdings IncRANI | 1 | Strong Buy | $17.00 | N/A | Maintains | 3 years ago |
Intercept Pharmaceuticals IncICPT | 5 | Sell | $14.00 | N/A | Maintains | 3 years ago |
Lenz Therapeutics IncLENZ | 3 | Sell | $2.00 | N/A | Downgrades | 3 years ago |
Inovio Pharmaceuticals IncINO | 4 | Sell | $24.00 | N/A | Downgrades | 4 years ago |
Omeros CorpOMER | 2 | Hold | $4.00 | N/A | Downgrades | 4 years ago |
Vaxxinity IncVAXX | 1 | Strong Buy | $21.00 | N/A | Initiates Coverage On | 5 years ago |
Checkmate Pharmaceuticals IncCMPI | 1 | Strong Buy | $7.00 | N/A | Upgrades | 5 years ago |
Erasca IncERAS | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 5 years ago |
Century Therapeutics IncIPSC | 1 | Strong Buy | $34.00 | N/A | Initiates Coverage On | 5 years ago |
Y Mabs Therapeutics IncYMAB | 3 | Strong Buy | $56.00 | N/A | Upgrades | 5 years ago |
Esperion Therapeutics IncESPR | 2 | Hold | $35.00 | N/A | Downgrades | 6 years ago |
Seagen IncSGEN | 6 | Strong Buy | N/A | N/A | Upgrades | 6 years ago |
Damora Therapeutics IncDMRA | 1 | Strong Buy | $525.00 | N/A | Initiates Coverage On | 6 years ago |
Pmv Pharmaceuticals IncPMVP | 1 | Strong Buy | $42.00 | N/A | Initiates Coverage On | 6 years ago |
Sangamo Therapeutics IncSGMO | 1 | Strong Buy | $20.00 | N/A | Reinstates | 6 years ago |
Poseida Therapeutics IncPSTX | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 6 years ago |
Puma Biotechnology IncPBYI | 1 | Sell | $9.00 | N/A | Reinstates | 6 years ago |
Genfit SaGNFTY | 1 | Sell | $7.00 | N/A | Initiates Coverage On | 6 years ago |
Eidos Therapeutics IncEIDX | 1 | Hold | $51.00 | N/A | Initiates Coverage On | 6 years ago |
Coherent CorpCOHR | 1 | Strong Buy | $31.00 | N/A | Initiates Coverage On | 6 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Hold | $110.00 | N/A | Downgrades | 6 years ago |
United Therapeutics CorpUTHR | 2 | Strong Sell | $95.00 | N/A | Maintains | 7 years ago |
Myovant Sciences LtdMYOV | 2 | Strong Buy | $25.00 | N/A | Upgrades | 7 years ago |
Dbv Technologies SaDBVT | 3 | Hold | $80.00 | N/A | Downgrades | 8 years ago |
Gritstone Bio IncGRTSQ | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 8 years ago |
Neurocrine Biosciences IncNBIX | 2 | Strong Buy | $135.00 | N/A | Maintains | 8 years ago |
Prothena Corp Public Ltd CoPRTA | 2 | Strong Sell | N/A | N/A | Downgrades | 8 years ago |
Zymeworks IncZYME | 2 | Hold | N/A | N/A | Upgrades | 8 years ago |
Ironwood Pharmaceuticals IncIRWD | 1 | Hold | $20.00 | N/A | Maintains | 8 years ago |
Incyte CorpINCY | 2 | Strong Buy | $135.00 | N/A | Maintains | 8 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 2 | Hold | N/A | N/A | Downgrades | 8 years ago |
Acceleron Pharma IncXLRN | 2 | Strong Buy | $54.00 | N/A | Maintains | 8 years ago |
Celgene CorpCELG | 4 | Strong Buy | N/A | N/A | Upgrades | 8 years ago |
Alnylam Pharmaceuticals IncALNY | 4 | Strong Buy | $158.00 | N/A | Maintains | 9 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.